Eli Wallace

Biological Characterization of ARRY-142886 (AZD6244), a Potent, Highly Selective Mitogen-Activated Protein Kinase Kinase 1/2 Inhibitor

Tammie C. Yeh, Vivienne Marsh, Bryan A. Bernat et al. · Clinical Cancer Research · 2007 · 575 citations · Full text

Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation

Kurtis D. Davies, P. LouAnn Cable, Jennifer Garrus et al. · Cancer Biology & Therapy · 2011 · 76 citations · Full text

Cell Death, Cell Cycle, Sirna Screen +21

Abstract 2515: Preclinical Development of ARRY-162, A Potent and Selective MEK 1/2 Inhibitor

Patrice A. Lee, Eli Wallace, Allison Marlow et al. · Cancer Research · 2010 · 37 citations

Immunology, Pharmacotherapy, Selective Mek 1/2 +18

Discovery of BBO-8520, a First-In-Class Direct and Covalent Dual Inhibitor of GTP-Bound (ON) and GDP-Bound (OFF) KRASG12C

Anna E. Maciag, James P. Stice, Bin Wang et al. · Cancer Discovery · 2024 · 33 citations · Full text

Molecular Biology, Direct Target Coverage, Adaptive Resistance +19

Diaminoindanes as Microsomal Triglyceride Transfer Protein Inhibitors

Gary M. Ksander, Reynalda deJesus, Andrew Yuan et al. · Journal of Medicinal Chemistry · 2001 · 32 citations · Full text

Metabolic Syndrome, Lipid Synthesis, Biochemistry +12